FDx Advisors’s Genmab GMAB Stock Holding History
Bought
Maintained
Sold
Other funds holding GMAB
HL
FDx Advisors's GMAB Position: Q4 2023 in Review
FDx Advisors sold out of Genmab (GMAB) in Q4 2023, closing a stake of 7,007 shares — an estimated $247K sold.
FDx Advisors first reported a position in GMAB in Q3 2019 and held it in 16 quarters. The position peaked at $1.17M in Q3 2021. 225 funds tracked by Wall St. Rank hold GMAB as of Q4 2023.
- FDx Advisors reported no remaining Genmab position as of Q4 2023 after selling out during the quarter.
- FDx Advisors sold 7,007 Genmab shares in Q4 2023, an estimated $247K.
- FDx Advisors first reported a position in Genmab in Q3 2019 and held it in 16 quarters.
- FDx Advisors's Genmab position peaked at $1.17M in Q3 2021.
- 225 funds tracked by Wall St. Rank held Genmab as of Q4 2023.
Based on FDx Advisors's 13F filing for Q4 2023, filed 13 Feb 2024.